Diglycolic acid, also known as 2,2'-oxydiacetic acid, is a dicarboxylic acid. It is a white solid that is soluble in water and has a variety of applications. It is commonly used in the synthesis of polymers, resins, and pharmaceuticals. Diglycolic acid is also used as a chelating agent, a sequestering agent, and a buffer. Diglycolic acid can be synthesized by the reaction of chloroacetic acid with sodium hydroxide. It can also be produced by the reaction of formaldehyde with glyoxylic acid. Diglycolic acid is a relatively non-toxic compound, but it can cause skin and eye irritation. It is important to handle it with care. Diglycolic acid is studied for its potential use in a variety of applications, including the production of biodegradable plastics, the removal of heavy metals from wastewater, and the development of new pharmaceuticals.'
diglycolic acid: nephrotoxic metabolite in diethylene glycol poisoning inducing necrosis in human proximal tubule cells
ID Source | ID |
---|---|
PubMed CID | 8088 |
CHEMBL ID | 1234950 |
CHEBI ID | 169983 |
SCHEMBL ID | 26928 |
MeSH ID | M0572598 |
Synonym |
---|
3-oxapentanedioic acid |
ai3-24216 |
nsc 8651 |
bis(carboxymethyl)ether |
2,2'-oxybisacetic acid |
oxydi(acetic acid) |
brn 1072117 |
oxodiacetic acid |
einecs 203-823-5 |
CHEBI:169983 |
2-(carboxymethoxy)acetic acid |
CHEMBL1234950 |
110-99-6 |
2,2'-oxydiacetic acid |
nsc8651 |
nsc-8651 |
oxydiacetic acid |
acetic acid,2'-oxybis- |
oxybisacetic acid |
oxydiethanolic acid |
diglycolic acid |
acetic acid, oxydi- |
bis(carboxymethyl) ether |
acetic acid, 2,2'-oxybis- |
inchi=1/c4h6o5/c5-3(6)1-9-2-4(7)8/h1-2h2,(h,5,6)(h,7,8 |
oeg , |
diglycolic acid, 98% |
D0545 |
diglycolicacid |
AKOS000120337 |
NCGC00248264-01 |
dtxsid4041575 , |
NCGC00254938-01 |
dtxcid2021575 |
cas-110-99-6 |
tox21_301036 |
unii-s4651635e0 |
s4651635e0 , |
FT-0624933 |
SCHEMBL26928 |
3-oxapentane-1,5-dioic acid |
.alpha.,.alpha.-oxydiacetic acid |
anhydroglycolic acid |
J-520322 |
J-002501 |
mfcd00004309 |
Z57965384 |
Q5276305 |
BS-14418 |
CCG-351657 |
EN300-18458 |
AMY41875 |
2,2-oxydiacetic acid; diglycollic acid; diglylollic acid |
A894817 |
CS-0158474 |
Diglycolic acid (DGA) is a byproduct produced by this condensation which cannot be completely removed.
Excerpt | Reference | Relevance |
---|---|---|
"Diglycolic acid (DGA) is a byproduct produced by this condensation which cannot be completely removed." | ( Analysis of diglycolic acid in food packaging, over the counter products, direct additive carboxymethyl cellulose, and retail foods. DeJager, L; Young, W, 2018) | 1.58 |
Excerpt | Reference | Relevance |
---|---|---|
"Diglycolic acid (DGA) has been identified as the metabolite responsible for the nephrotoxicity and hepatotoxicity." | ( Diglycolic acid inhibits succinate dehydrogenase activity, depletes mitochondrial membrane potential, and induces inflammation in an SH-SY5Y neuroblastoma model of neurotoxicity in vitro. Landry, GM; Reed, KJ, 2023) | 3.07 |
Excerpt | Relevance | Reference |
---|---|---|
"Adult male Wistar rats were divided into three groups dosed with 0, 100 or 300 mg/kg DGA via single oral gavage." | ( In-vivo evidence of nephrotoxicity and altered hepatic function in rats following administration of diglycolic acid, a metabolite of diethylene glycol. Abreo, F; Broussard, K; Latimer, B; McMartin, KE; Robinson, CN, 2017) | 0.67 |
" The steep dose-response threshold for toxicity suggests mechanistically that there is likely a saturable step that results in DGA accumulation in target organs." | ( In-vivo evidence of nephrotoxicity and altered hepatic function in rats following administration of diglycolic acid, a metabolite of diethylene glycol. Abreo, F; Broussard, K; Latimer, B; McMartin, KE; Robinson, CN, 2017) | 0.67 |
" Given that DGA is present in our food supply as a chemical byproduct of carboxymethyl starch food additives, we sought to perform in vitro testing of its potential hepatotoxicity to help complement a recent in vivo rat acute dose-response study that also tested for the potential hepatotoxic effects of daily DGA ingestion by oral gavage over a period of 28 days." | ( Diglycolic acid induces HepG2/C3A liver cell toxicity in vitro. Belgrave, K; Black, T; Depina, A; Flynn, TJ; Keltner, Z; Mossoba, ME; Olejnik, N; Pugh-Bishop, S; Sprando, J; Sprando, RL; Toomer, H; Topping, V; Vohra, S; Wiesenfeld, PL, 2018) | 1.92 |
Class | Description |
---|---|
dicarboxylic acid | Any carboxylic acid containing two carboxy groups. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 0.0044 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 6.7860 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (57.14) | 24.3611 |
2020's | 8 (38.10) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (34.31) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 22 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |